SCHEMBL25322344

SCHEMBL25322344

CC(=O)Nc1ccc(Nc2nc(-c3sc(N)nc3C)cs2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.80
KMT2A Q03164 7/20 0.80
POLB P06746 2/20 0.80
NPC1 O15118 4/20 0.72
RAB9A P51151 2/20 0.72
GAA P10253 6/20 0.70
ALDH1A1 P00352 4/20 0.70
MAPT P10636 4/20 0.70
HSD17B10 Q99714 3/20 0.70
USP2 O75604 2/20 0.70
ALOX15 P16050 2/20 0.70
CLK1 P49759 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
TDP1 Q9NUW8 3/20 0.69
TSHR P16473 2/20 0.69
LMNA P02545 2/20 0.69
KDM4E B2RXH2 1/20 0.69
HTT P42858 1/20 0.69
GFER P55789 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4518527 0.89 MEN1 (1.00) MEN1KMT2APOLBRAB9AGAA
SCHEMBL23270917 0.88 MEN1 (0.76) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL4515151 0.86 MEN1 (0.85) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL25920958 0.84 MEN1 (0.72) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL8738403 0.83 MEN1 (0.70) MEN1KMT2APOLBNPC1GAA
SCHEMBL4533989 0.83 MEN1 (0.89) MEN1KMT2APOLBRAB9AGAA
SCHEMBL25920953 0.83 MEN1 (0.64) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL4524776 0.83 MEN1 (0.83) MEN1KMT2APOLBRAB9AGAA
SCHEMBL4526537 0.82 MEN1 (0.98) MEN1KMT2APOLBRAB9AGAA
SCHEMBL29170022 0.82 NPC1 (1.00) MEN1KMT2APOLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4333843-A1 BITHIAZOL DERATIVES AS INHIBITORS OF LYSYL OXIDASES University of South Carolina (US) 2024-03-13 EP disclosed
US-20240075015-A1 Inhibitors of Lysyl Oxidases UNIVERSITY OF SOUTH CAROLINA 2024-03-07 US disclosed
CN-117545480-A Dithiazole derivatives as inhibitors of lysyl oxidase 南卡罗来纳大学 2024-02-09 CN disclosed
US-11712437-B2 Inhibitors of lysyl oxidases UNIVERSITY OF SOUTH CAROLINA (US) 2023-08-01 US disclosed
US-11712437-B2 Inhibitors of lysyl oxidases UNIVERSITY OF SOUTH CAROLINA (US) 2023-08-01 US disclosed
US-20220378753-A1 NOVEL INHIBITORS OF LYSYL OXIDASES UNIVERSITY OF SOUTH CAROLINA (US) 2022-12-01 US disclosed
WO-2022240476-A1 BITHIAZOL DERATIVES AS INHIBITORS OF LYSYL OXIDASES UNIVERSITY OF SOUTH CAROLINA (US) 2022-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240075015-A1 Inhibitors of Lysyl Oxidases LOXL1, LOXL2, LOXL4 MEN1 4801/4885KMT2A 1235/4885POLB 2469/4885
US-20220378753-A1 NOVEL INHIBITORS OF LYSYL OXIDASES LOXL1, LOXL2, LOXL4 MEN1 4832/4885KMT2A 1441/4885POLB 3076/4885
US-11712437-B2 Inhibitors of lysyl oxidases LOXL1, LOXL2, LOXL4 MEN1 4808/4885KMT2A 1401/4885POLB 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.